HOME | OUR COMPANY | PRODUCT PORTFOLIO | PRESS ROOM| INVESTORS | CAREERS | CONTACT US
SITE MAP | TERMS OF USE | PRIVACY POLICY

emergent biosolutions logo
Home Page
Our Company
spi-VEC TM

About MVA

Key Benefits of MVAtorTM (Viral Vaccine Vector)

  • Versatility - Tool for gene expression and vaccine development
  • Safety - Designed to be free of transmissible spongiform encephalitis (TSE) issues

MVAtor is a registered trademark in Germany, a pending trademark in the European Community and is owned by Emergent.

OUR COMPANY Product Portfolio Press Room INVESTORS CAREERS CONTACT US